Bellevue Group AG trimmed its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,286 shares of the biotechnology company’s stock after selling 4,466 shares during the […]
Bellevue Group AG trimmed its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 290,206 shares of the company’s stock after selling 1,690 shares during the period. Bellevue Group AG’s […]
Bellevue Group AG trimmed its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 290,206 shares of the company’s stock after selling 1,690 shares during the period. Bellevue Group AG’s […]
Bellevue Group AG lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,535,656 shares of the healthcare product maker’s stock after selling 25,312 shares during the quarter. Abbott Laboratories accounts […]
Bellevue Group AG grew its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 51.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 970,772 shares of the medical technology company’s stock after buying an additional 329,280 shares during the period. Medtronic accounts […]